Genomics England
| Formation | 5 July 2013 |
|---|---|
| Headquarters | One Canada Square, Canary Wharf, London, England |
Parent organization | Department of Health and Social Care |
| Website | www |
Preview warning: Page using Template:Infobox organization with deprecated parameter
membership. Replace with num_members.Preview warning: Page using Template:Infobox organization with deprecated parameter
map2_alt. It should be removed.Preview warning: Page using Template:Infobox organization with deprecated parameter
map2_caption. It should be removed.Preview warning: Page using Template:Infobox organization with deprecated parameter
map2_size. It should be removed.Preview warning: Page using Template:Infobox organization with deprecated parameter
map2. It should be removed.Preview warning: Page using Template:Infobox organization with deprecated parameter
purpose. It should be removed.Genomics England is a company wholly owned by the United Kingdom's Department of Health and Social Care. Established in 2013, it was tasked with delivering the 100,000 Genomes Project, a pioneering initiative that sequenced 100,000 genomes from approximately 85,000 National Health Service patients affected by rare conditions and cancers. This project paved the way for the NHS to incorporate genomic medicine into routine care through the NHS Genomic Medicine Service.
In March 2024, Dr. Rich Scott was appointed Chief Executive Officer of Genomics England, having first joined the organisation in 2015.